Study to Evaluate Safety, Tolerability, Pharmacokinetics and the Food Effect on PK of ASC10 Tablets in Healthy Subjects

Inclusion Criteria: * Male or female volunteers between the ages 18 and 45, inclusive * Those who do not have plans for pregnancy within six months and are willing to take effective contraceptive measures from the first dose of the study drug to 3 months after the last dose. * If male, agree to use adequate contraception throughout the study and for at least 3 months after the last dose of study drug. * Body mass index (BMI) was between 19 and 26 kg/m\^2. Weight ≥50 kg for males and ≥45 kg for females. Exclusion Criteria: * Females who are pregnant, planning to become pregnant, or breastfeeding. * Has any current or historical disease or disorder of the hematological system or significant liver disease or family history of bleeding/platelet disorders. * Has a history of cancer (other than basal cell or squamous cell cancer of the skin), rheumatologic disease or blood dyscrasias. * Has a history of blood dizziness or difficulty in blood collection. * Has donated blood within 30 days, plasma within 2 weeks, or platelets within 6 weeks before the first dose of study drug.